The transfusion effect

Area of Science:

• Nephrology
• Immunology
• Transplantation Science

Background:

• The impact of pretransplant blood transfusions on kidney allograft survival has been a subject of ongoing research.
• Cyclosporine has revolutionized immunosuppression, but its interaction with transfusion effects requires clarification.
• Understanding factors influencing graft survival is crucial for improving patient outcomes in kidney transplantation.

Purpose of the Study:

• To evaluate the independent and combined effects of pretransplant transfusions, cyclosporine, and HLA-B,DR matching on cadaveric kidney graft survival.
• To assess the efficacy of pretransplant transfusions in different patient age groups and for first versus second grafts.
• To determine the role of peroperative transfusions in kidney transplant recipients.

Main Methods:

• Retrospective analysis of kidney transplant recipient data, comparing graft survival rates based on transfusion status (pretransplant and peroperative).
• Statistical comparisons (p-values) were used to assess the significance of transfusion effects.
• Analysis stratified by cyclosporine use, patient age, HLA matching, and graft number (first vs. second).

Main Results:

• Pretransplant transfusions significantly improved one-year graft survival rates, both with and without cyclosporine (77% vs. 66% with CsA; 64% vs. 57% without CsA).
• The transfusion effect was most significant in patients aged 16-40 and acted independently of cyclosporine and HLA-B,DR matching.
• Peroperative transfusions were beneficial for regrafted patients but showed a slight negative impact on first grafts, particularly in males.

Conclusions:

• Pretransplant blood transfusions remain a critical factor in enhancing kidney allograft survival, independent of modern immunosuppression and HLA matching.
• The benefits of transfusions are most evident in younger recipients and for subsequent grafts, suggesting an immunomodulatory role.
• While peroperative transfusions may benefit regrafted patients, their role in primary transplants requires further investigation.